Cabergoline lactation drug may reduce breast cancer risk in mothers, study finds
An international team of scientists has found that cabergoline, a medication used to stop milk production after pregnancy, could reduce the risk of breast cancer in mothers after childbirth.
2 sourcesWomen’s health
00